Share-based Payment Arrangement, Expense of Propanc Biopharma, Inc. from 30 Sep 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Propanc Biopharma, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2021 to 31 Dec 2025.
  • Propanc Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $1,789,262.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)

Propanc Biopharma, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,789,262 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q2
Q3 2022 $0 -$20,718 -100% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q3 2021 $20,718 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1

Propanc Biopharma, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $4,621,230 01 Jul 2024 30 Jun 2025 10-Q 17 Feb 2026 2026 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.